Navigation Links
Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease
Date:9/22/2008

DEERFIELD, Ill., Sept. 22 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced initiation of a Phase III clinical trial following U.S. Food and Drug Administration (FDA) review of its investigational new drug application to evaluate GAMMAGARD LIQUID [Immune Globulin Intravenous (IGIV)], marketed as KIOVIG in European Union, for the treatment of mild-to-moderate Alzheimer's disease. This trial is expected to be the first of two pivotal Phase III trials required to support filing for regulatory approval for GAMMAGARD LIQUID as a potential treatment for the disease.

The Phase III trial is a prospective, 18-month, randomized, double-blind, placebo-controlled, two dose-arm, parallel study in 360 subjects of both genders, ages 50 to 89 years old, with dementia of mild-to-moderate severity. The study will determine whether GAMMAGARD LIQUID treatment results in a significantly slower rate of decline of cognitive and other functions compared to placebo. Approximately 40 U.S. leading academic centers have been identified and will begin clinical trial enrollment within the next several weeks.

Efficacy will be assessed by two primary endpoints:

-- Cognitive outcomes using the Alzheimer's Disease Assessment Scale- Cognitive Subscale score (ADAS-Cog), and

-- Global clinical outcome as assessed by the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change rating (ADCS-CGIC).

Secondary endpoints to be assessed at 18 months include behavioral, functional and quality of life outcome measures. Other secondary endpoints will include several plasma, cerebrospinal fluid, and imaging biomarkers to assess disease progression and response to therapy.

The trial is sponsored by Baxter and partially funded by the National Institutes of Health (NIH) through the Alzheimer's Disease Cooperative Study (ADCS). The ADCS is a cooperative agreement between the National Institute of Aging and the University of Calif
'/>"/>

SOURCE Baxter Healthcare Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
2. Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously
3. Baxter Announces Recombinant Factor IX Development Program For Hemophilia B
4. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
5. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
6. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
7. S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies
8. Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA
9. QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome
10. Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections
11. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Mount Elizabeth Novena Hospital will soon become the first ... treat cancer using the TrueBeam™ STx system for radiotherapy ... VAR ).  At a Grand Opening event last Friday, ... of treatment including radiosurgery, a precise method of using ... from outside the body, without performing surgery.  ...
(Date:3/2/2015)... -- Valencia Technologies Corporation (" Valencia ") ... small device for the treatment of high blood pressure ... double-blinded, controlled trial are compelling and provide the Company ... succeed in a large U.S. trial for FDA approval. ... Valencia has successfully raised more than 2.2 ...
(Date:3/2/2015)... SOUTH SAN FRANCISCO, Calif. , March 2, ... therapeutics for the treatment of cancer, today announced ... comprised of leading researchers and clinicians in the ... The new advisory boards will ... its wholly owned pipeline of precision immunotherapies and ...
Breaking Medicine Technology:Mount Elizabeth Novena Hospital to Deliver First TrueBeam STx Radiosurgery Treatments in Singapore 2Mount Elizabeth Novena Hospital to Deliver First TrueBeam STx Radiosurgery Treatments in Singapore 3Valencia Technologies Implants its 48th Patient, Continues Equity Crowdfunding 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3
... OAKLAND, Tenn., Feb. 23, 2011 Plexus Biomedical Inc. ... the Food and Drug Administration to market the first ... vaginal childbirth. Hemorrhoids associated with vaginal delivery are a ... 1,000,000 pregnant women in the U.S. every year. ...
... 2011 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) ... investor conferences in March: Citi,s 2011 Global Healthcare Conference , ... Capital Markets, Healthcare Conference , Thursday, March 3, at ... Healthcare Conference , Wednesday, March 9, at 10:15 a.m. ET ...
Cached Medicine Technology:Plexus Biomedical Inc. Gains FDA Approval of the First Medical Device to Help Prevent External Hemorrhoids During Vaginal Childbirth 2
(Date:3/2/2015)... Dinner preparation and meal planning have ... of DinnerDork , a company that specializes ... thousands of busy customers. The company recently responded ... offer a total of 6 diverse meal plan ... recipes and comfort foods; Paleo Palette, which caters ...
(Date:3/2/2015)... Four Seasons Resort Maui at Wailea, the ... this year, having officially opened its doors on March 2, ... honoring over 70 employees who started on Day 1 and ... approximately 400 original employees. The celebration will be a ... , This Four Seasons flagship resort, the first resort ...
(Date:3/2/2015)... 2015 A true renaissance man—some might call ... 1960s cult rock band Khazad Doom, has long inspired his ... persevere despite all odds. His motto throughout his life has ... or goal was before him. And that attitude, born amidst ... passed on to a new generation. , As Eadon knows, ...
(Date:3/2/2015)... Houston, TX (PRWEB) March 02, 2015 ... CV? How should physicians request references? When are interviews ... physicians analyze employment opportunities?, Both training and practicing physicians ... answers to these questions and more at the PracticeLink ... March 18. The drop-in Job Fair is from 5:30 ...
(Date:3/2/2015)... Many mainstream media outlets have run ... But how much of that news reporting is true? ... prevent measles, but whose youngsters later developed autism, will ... speakers comprised of professionals, clinicians, researchers, therapists, advocates, and ... and questions about the body and childhood health will ...
Breaking Medicine News(10 mins):Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 3Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2Health News:Growing List of Professionals Gather for World’s Most Comprehensive Autism Conference in Chicago, May 2015 2
... professor of pharmacology and a member of UNC Lineberger ... Innovative Research Grants from Stand Up to Cancer, the ... The grants were announced during an event at ... Meeting 2011. SU2C,s Innovative Research Grants Program, which ...
... University of California, San Diego School of Medicine say a ... harsh or demanding conditions is exploited by cancer cells, which ... inflammatory response in them that can aid tumor growth. ... medicine and director of the Laboratory of Immunology at the ...
... 4 (HealthDay News) -- A minimally invasive treatment for ... among seniors -- appears to be as effective as ... take about two hours to perform, the newer alternative ... a catheter-enabled insertion of a tiny clothespin-like device, called ...
... of Medicine,s Cosimo Commisso, PhD, a postdoctoral fellow in ... The Pancreatic Cancer Action Network-American Association for Cancer Research ... research. Dr. Commisso was honored at the American Association ... 2-6, in Orlando, Florida. Dr. Commisso will receive ...
... that reign during relapses of an aggressive human leukemia are ... a paper published online on April 4 in the ... By comparing the DNA of cancer cells taken at the ... acute lymphoblastic leukemia (T-ALL), Jean Soulier and co-workers found that ...
... calculator can predict the risk of postoperative complications occurring for ... the March issue of the Journal of the American ... surgical decision-making and will help patients better understand what they ... bariatric operation. The study authors developed the risk ...
Cached Medicine News:Health News:Call of the riled 2Health News:Clamp Device for Leaky Heart Valve Seems Effective 2Health News:Clamp Device for Leaky Heart Valve Seems Effective 3Health News:NYU School of Medicine researcher receives Pancreatic Cancer Action Network- AACR fellowship 2Health News:New tool helps surgeons predict patients' risk of complications after bariatric operations 2
Shandon Microscope Slide Trays...
... is the first solid-state,photocoagulator to ... wavelengths. This advanced,laser system makes ... a red or green wavelength,during ... and ensures effective,patient results., For ...
... Gathering, managing, and transmitting data ... you were hired for. Dawnings ResultNet/Plus ... running your lab, not your communications ... with transmitting result data from largescale ...
... Horizon Cardiology Hemo is a comprehensive ... for the cath lab. Patient ... cardiac images and procedural information all ... patient record, eliminating repetitive data entry. ...
Medicine Products: